ATE401067T1 - Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie - Google Patents

Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie

Info

Publication number
ATE401067T1
ATE401067T1 AT04803913T AT04803913T ATE401067T1 AT E401067 T1 ATE401067 T1 AT E401067T1 AT 04803913 T AT04803913 T AT 04803913T AT 04803913 T AT04803913 T AT 04803913T AT E401067 T1 ATE401067 T1 AT E401067T1
Authority
AT
Austria
Prior art keywords
gynecomastia
hydroxy tamoxifen
patients
patient
hydroxytamoxifen
Prior art date
Application number
AT04803913T
Other languages
English (en)
Inventor
Nestour Elisabeth Le
Andrew Palumbo
Original Assignee
Besins Int Lab
Ascend Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/734,640 external-priority patent/US7786172B2/en
Priority claimed from EP03293156A external-priority patent/EP1550440A1/de
Application filed by Besins Int Lab, Ascend Therapeutics Inc filed Critical Besins Int Lab
Application granted granted Critical
Publication of ATE401067T1 publication Critical patent/ATE401067T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04803913T 2003-12-15 2004-12-13 Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie ATE401067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/734,640 US7786172B2 (en) 2002-12-18 2003-12-15 Treatment of mastalgia with 4-hydroxy tamoxifen
EP03293156A EP1550440A1 (de) 2003-12-15 2003-12-15 Verwendung von 4-hydroxytamoxifen zur Herstellung eines Arzneimittels zur Behandlung von Gynäkomastie

Publications (1)

Publication Number Publication Date
ATE401067T1 true ATE401067T1 (de) 2008-08-15

Family

ID=34702366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803913T ATE401067T1 (de) 2003-12-15 2004-12-13 Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie

Country Status (14)

Country Link
EP (1) EP1694319B1 (de)
JP (1) JP5069469B2 (de)
AT (1) ATE401067T1 (de)
AU (1) AU2004298349B2 (de)
CA (1) CA2549824C (de)
DE (1) DE602004015146D1 (de)
DK (1) DK1694319T3 (de)
ES (1) ES2310765T3 (de)
MX (1) MXPA06006834A (de)
NO (1) NO336463B1 (de)
NZ (1) NZ547744A (de)
PL (1) PL1694319T3 (de)
PT (1) PT1694319E (de)
WO (1) WO2005058297A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1946387B (zh) * 2004-03-22 2011-08-31 法国法杏大药厂 4-羟基三苯氧胺在制备治疗和预防良性乳房疾病的药物中的应用
EP1579857A1 (de) * 2004-03-22 2005-09-28 Laboratoires Besins International Stabile Zusammensetzungen enthaltend 4-hydroxy Tamoxifen
EP1799201B1 (de) * 2004-10-14 2008-11-26 Laboratoires Besins International 4-hydroxytamoxifengel-formulierungen
RU2373977C1 (ru) * 2008-08-05 2009-11-27 Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Способ лечения болевого синдрома при викарном увеличении яичника после односторонней аднексэктомии
GB2608397B (en) * 2021-06-29 2025-04-09 Chaitowitz Ilan Gynecomastia treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
IL120268A0 (en) * 1996-02-28 1997-06-10 Pfizer Use of (E)-1-[4'-(2-alkylaminoethioxy)phenyl]1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ATE288303T1 (de) * 2000-11-30 2005-02-15 Pfizer Prod Inc Östrogen agonist-antagonist und testosteron enthaltende zusammensetzung zur behandlung abnehmender testosteronspiegel
JP2005504032A (ja) * 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
PT1317921E (pt) * 2001-12-07 2009-11-06 Besins Mfg Belgium Composição farmacêutica sob a forma de gel ou de solução à base de di-hidrotestosterona, seu processo de preparação e suas utilizações
US7767717B2 (en) * 2003-06-09 2010-08-03 Ascend Therapeutics, Inc. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
WO2005058297A1 (en) 2005-06-30
AU2004298349B2 (en) 2010-02-25
ES2310765T3 (es) 2009-01-16
PL1694319T3 (pl) 2009-01-30
HK1094768A1 (en) 2007-04-13
JP5069469B2 (ja) 2012-11-07
NO336463B1 (no) 2015-08-31
NO20062904L (no) 2006-06-21
PT1694319E (pt) 2008-10-24
EP1694319A1 (de) 2006-08-30
DK1694319T3 (da) 2008-11-17
CA2549824C (en) 2012-03-13
NZ547744A (en) 2009-09-25
JP2007529420A (ja) 2007-10-25
DE602004015146D1 (de) 2008-08-28
EP1694319B1 (de) 2008-07-16
AU2004298349A1 (en) 2005-06-30
MXPA06006834A (es) 2006-09-04
CA2549824A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
Rosique et al. Gluteoplasty with autologous fat tissue: experience with 106 consecutive cases
NO20054526L (no) Forebygging og behandling av brystkreft med 4-hydroxy tamoxifen
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
Di Chiacchio et al. Nail abrasion
Kästner et al. Removal of polyacrylamide gel (Aquamid®) from the lip as a solution for late-onset complications: our 8-year experience
Ahmed Rehabilitation of nose using silicone based maxillofacial prosthesis
Zingaretti et al. Evaluation of Kinesio taping for edema, ecchymosis, and pain after liposuction: a prospective pilot study
ATE401067T1 (de) Verwendung von 4-hydroxytamoxifen zur herstellung eines medikaments zur behandlung von gynäkomastie
de la Peña et al. Subfascial gluteal augmentation
Senderoff Practice-based patient management strategies in gluteal augmentation with implants
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE391499T1 (de) 4-hydroxytamoxifen zur behandlung und prophylaxe von benignen brusterkrankungen
Majid et al. Ultrathin skin grafting in resistant stable vitiligo: A follow-up study of 8 years in 370 patients
JOP20200046A1 (ar) طرق لعلاج أمراض مرتبطة بـtnf?
RU2222319C2 (ru) Способ регионарной лимфостимуляции и обезболивания при лимфедеме нижних конечностей
US20120271216A1 (en) Surgical pin compressive wound dressing housing
RU2332990C1 (ru) Способ лечения трофических язв у больных сахарным диабетом
Dupuis Smaller teams for humanitarian missions in the Third World
Kolomiets Prolonged intravenous infusion therapy of lidocaine in treatment of chronic venous insufficiency in C6 and C6R stage
Kang et al. Applications of vacuum-assisted closure device in maxillofacial reconstruction
Khallaf BUTTOCK AUGMENTATION WITH FAT TRANSERFERE: EXPERIENCE WITH 200 CASES
Dholam et al. Implant-retained orbital prosthesis
RU164775U1 (ru) Способ лечения пролежней седалищной области
Blugerman et al. Minimal Invasive Calf Augmentation
Prendergast Breast Augmentation with Hyaluronic Acid Filler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1694319

Country of ref document: EP